These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36863975)

  • 1. Impact of Left Ventricular Outflow Tract Obstruction on Coronary Physiological Assessment.
    Harano Y; Kawase Y; Warisawa T; Matsuo H
    Cardiovasc Revasc Med; 2023 Aug; 53S():S317-S319. PubMed ID: 36863975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
    Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
    Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered autonomic cardiac control in hypertrophic cardiomyopathy. Role of outflow tract obstruction and myocardial hypertrophy.
    Limbruno U; Strata G; Zucchi R; Baglini R; Mengozzi G; Balbarini A; Mariani M
    Eur Heart J; 1998 Jan; 19(1):146-53. PubMed ID: 9503188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of discordance between fractional flow reserve and resting full-cycle ratio in patients with coronary artery disease: Evidence from clinical practice.
    Kato Y; Dohi T; Chikata Y; Fukase T; Takeuchi M; Takahashi N; Endo H; Nishiyama H; Doi S; Okai I; Iwata H; Isoda K; Okazaki S; Miyauchi K; Daida H; Minamino T
    J Cardiol; 2021 Mar; 77(3):313-319. PubMed ID: 33234404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom assessment and exercise impairment in surgical decision making in hypertrophic obstructive cardiomyopathy: Relationship to outcomes.
    Desai MY; Smedira NG; Bhonsale A; Thamilarasan M; Lytle BW; Lever HM
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):928-35.e1. PubMed ID: 26318357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transapical beating-heart septal myectomy for recurrent left ventricular outflow tract obstruction after septal reduction therapy in hypertrophic obstructive cardiomyopathy.
    Li J; Li C; Wei X
    Eur J Cardiothorac Surg; 2023 Sep; 64(3):. PubMed ID: 37665748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy.
    Dimitrow PP; Czarnecka D; Strojny JA; Kawecka-Jaszcz K; Dubiel JS
    Int J Cardiol; 2001 Jan; 77(1):43-8. PubMed ID: 11150624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with discordance between fractional flow reserve and resting full-cycle ratio.
    Yamazaki T; Saito Y; Kobayashi T; Kitahara H; Kobayashi Y
    J Cardiol; 2022 Jul; 80(1):9-13. PubMed ID: 35256215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of acute intravenous landiolol in Takotsubo cardiomyopathy with dynamic left ventricular outflow tract obstruction.
    Cho Y; Inoue K; Kunimoto M; Minamino T
    BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37844977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of hypertrophic cardiomyopathy with left ventricular outflow tract obstruction using a covered stent.
    Pekas D; Chawda A; Desai N
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36535735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between resting full-cycle ratio and fractional flow reserve in assessments of coronary stenosis severity.
    Muroya T; Kawano H; Hata S; Shinboku H; Sonoda K; Kusumoto S; Eto R; Otsuka K; Maemura K
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E432-E438. PubMed ID: 32134192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of left ventricular outflow tract cross-sectional area in hypertrophic cardiomyopathy: a two-dimensional echocardiographic assessment.
    Spirito P; Maron BJ
    Circulation; 1983 May; 67(5):1100-8. PubMed ID: 6682018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Betocchi S; Casey SA; Lesser JR; Losi MA; Cecchi F; Maron BJ
    N Engl J Med; 2003 Jan; 348(4):295-303. PubMed ID: 12540642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
    Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
    J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.
    Stewart M; Elagizi A; Gilliland YE
    Curr Opin Cardiol; 2023 Sep; 38(5):405-414. PubMed ID: 37115813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve.
    Mileva N; Ohashi H; Paolisso P; Leipsic J; Mizukami T; Sonck J; Norgaard BL; Otake H; Ko B; Maeng M; Munhoz D; Nagumo S; Belmonte M; Vassilev D; Andreini D; Barbato E; Koo BK; De Bruyne B; Collet C
    Catheter Cardiovasc Interv; 2023 Jun; 101(7):1182-1192. PubMed ID: 37102381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Submitral Apparatus in Hypertrophic Obstructive Cardiomyopathy.
    Tao J; Duan F; Long J; Meng Q; Zhang B; Zhu Z; Wang H
    J Am Soc Echocardiogr; 2023 Feb; 36(2):133-145. PubMed ID: 36191671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.